United States v. Johnson
Annotate this Case
221 U.S. 488 (1911)
- Syllabus |
U.S. Supreme Court
United States v. Johnson, 221 U.S. 488 (1911)
United States v. Johnson
Argued April 13, 1911
Decided May 29, 1911
221 U.S. 488
ERROR TO THE DISTRICT COURT OF THE UNITED STATES
FOR THE WESTERN DISTRICT OF MISSOURI
The term "misbranded" and the phrase defining what amounts to misbranding in § 8 of the Food and Drugs Act of June 30, 1906, 34 Stat. 768, c. 3915, are aimed at false statements as to identity of the article, possibly including strength, quality and purity, dealt with in § 7 of the act, and not at statements as to curative effect, and so held that a statement on the labels of bottles of medicine that the contents are effective as a cure for cancer, even if misleading, is not covered by the statute.
177 F. 313 affirmed.
The facts are stated in the opinion.
MR. JUSTICE HOLMES delivered the opinion of the Court.
This is an indictment for delivering for shipment from Missouri to Washington, District of Columbia, packages and bottles of medicine bearing labels that stated or implied that the contents were effective in curing cancer, the defendant well knowing that such representations were false. On motion of the defendant, the district judge quashed the indictment (177 F. 313), and the United States brought this writ of error under the Act of March 2, 1907, c. 2564, 34 Stat. 1246.
The question is whether the articles were misbranded within the meaning of § 2 of the Food and Drugs Act of June 30, 1906, c. 3915, 34 Stat. 768, making the delivery of misbranded drugs for shipment to any other state or territory or the District of Columbia a punishable offense. By § 6, the term "drug" includes any substance or mixture intended to be used for the cure, mitigation, or prevention of disease. By § 8, c. 3915, 34 Stat. 770, the
"shall apply to all drugs or articles of food, . . . the package or label of which shall bear any statement, design, or device regarding such article, or the ingredients or substances contained therein, which shall be false or misleading in any particular, and to any food or drug product which is falsely branded as to the state, territory, or country in which it is manufactured or produced. . . . An article shall also be deemed to be misbranded: In case of drugs: First. If it be an imitation of, or offered for sale under the name of, another article. Second. [In case of a substitution of contents] . . . or if the package fail to bear a statement on the label of the quantity or proportion of any alcohol, morphine, opium, cocaine, heroin, alpha or beta eucaine, chloroform, cannabis indica, chloral hydrate, or acetanilid, or any derivative or preparation of any such substances contained therein."
It is a postulate, as the case comes before us, that in a certain sense the statement on the label was false, or at least, misleading. What we have to decide is whether such misleading statements are aimed at and hit by the words of the act. It seems to us that the words used convey to an ear trained to the usages of English speech a different aim, and although the meaning of a sentence is to be felt, rather than to be proved, generally, and here, the impression may be strengthened by argument, as we shall try to show.
We lay on one side as quite unfounded the argument that the words "statement which shall be misleading in any particular," as used in the statute, do not apply to drugs at all -- that the statements referred to are those "regarding such article," and that "article" means article of food, mentioned by the side of drugs at the beginning of the section. It is enough to say that the beginning of the sentence makes such a reading impossible, and that "article" expressly includes "drugs," a few lines further on in what we have quoted, not to speak of the reason of the
thing. But we are of opinion that the phrase is aimed not at all possible false statements, but only at such as determine the identity of the article, possibly including its strength, quality, and purity, dealt within § 7. In support of our interpretation, the first thing to be noticed is the second branch of the sentence: "Or the ingredients or substances contained therein." One may say with some confidence that, in idiomatic English, this half at least, is confined to identity, and means a false statement as to what the ingredients are. Logically it might mean more, but idiomatically it does not. But if the false statement referred to is a misstatement of identity as applied to a part of its objects, idiom and logic unite in giving it the same limit when applied to the other branch, the article, whether simple or one that the ingredients compose. Again, it is to be noticed that the cases of misbranding, specifically mentioned, and following the general words that we have construed, are all cases analogous to the statement of identity, and not at all to inflated or false commendation of wares. The first is a false statement as to the country where the article is manufactured or produced -- a matter quite unnecessary to specify if the preceding words had a universal scope, yet added as not being within them. The next case is that of imitation and taking the name of another article, of which the same may be said, and so of the next, a substitution of contents. The last is breach of an affirmative requirement to disclose the proportion of alcohol and certain other noxious ingredients in the package -- again, a matter of plain past history concerning the nature and amount of the poisons employed, not an estimate or prophecy concerning their effect. In further confirmation, it should be noticed that, although the indictment alleges a willful fraud, the shipment is punished by the statute if the article is misbranded, and that the article may be misbranded without any conscious fraud at all. It was natural enough to throw this risk on
shippers with regard to the identity of their wares, but a very different and unlikely step to make them answerable for mistaken praise. It should be noticed still further that, by § 4, the determination whether an article is misbranded is left to the Bureau of Chemistry of the Department of Agriculture, which is most natural if the question concerns ingredients and kind, but hardly so as to medical effects.
To avoid misunderstanding, we should add that, for the purposes of this case, at least, we assume that a label might be of such a nature as to import a statement concerning identity, within the statute, although in form only a commendation of the supposed drug. It may be that a label in such form would exclude certain substances so plainly to all common understanding as to amount to an implied statement of what the contents of the package were not, and it may be that such a negation might fall within the prohibitions of the act. It may be (we express no opinion upon that matter) that, if the present indictment had alleged that the contents of the bottles were water, the label so distinctly implied that they were other than water as to be a false statement of fact concerning their nature and kind. But such a statement as to contents, undescribed and unknown, is shown to be false only in its commendatory and prophetic aspect, and as such is not within the act.
In view of what we have said by way of simple interpretation, we think it unnecessary to go into considerations of wider scope. We shall say nothing as to the limits of constitutional power, and but a word as to what Congress was likely to attempt. It was much more likely to regulate commerce in food and drugs with reference to plain matter of fact, so that food and drugs should be what they professed to be, when the kind was stated, than to distort the uses of its constitutional power to establishing criteria in regions where opinions are far apart. See School of
Magnetic Healing v. McAnnulty, 187 U. S. 94. As we have said above, the reference of the question of misbranding to the Bureau of Chemistry for determination confirms what would have been our expectation and what is our understanding of the words immediately in point.
MR. JUSTICE HUGHES, dissenting:
I am unable to concur in the judgment in this case, for the following reasons:
The defendant was charged with delivering for shipment in interstate commerce certain packages and bottles of drugs alleged to have been misbranded in violation of the Food and Drugs Act of June 30, 1906, chapter 3915, 34 Stat. 768.
The articles were labeled respectively "Cancerine tablets," "Antiseptic tablets," "Blood purifier," "Special No. 4," "Cancerine No. 17," and "Cancerine No. 1" -- the whole constituting what was termed in substance "Dr. Johnson's Mild Combination Treatment for Cancer." There were several counts in the indictment with respect to the different articles. The labels contained the words, "Guaranteed under the Pure Food and Drugs Act, June 30, 1906," and some of the further statements were as follows:
"Blood Purifier. This is an effective tonic and alternative. It enters the circulation at once, utterly destroying and removing impurities from the blood and entire system. Acts on the bowels, kidneys, and skin, eliminating poisons from the system, and when taken in connection with the Mild Combination Treatment, gives splendid results in the treatment of cancer and other malignant diseases. I always advise that the Blood Purifier be continued some little time after the cancer has been killed and removed and the sore healed. "
"Special No. 4. . . . It has a strong stimulative and absorptive power; will remove swelling, arrest development, restore circulation, and remove pain. Is indicated in all cases of malignancy where there is a tendency of the disease to spread, and where there is considerable hardness surrounding the sore. Applied thoroughly to a lump or to an enlarged gland, will cause it to soften, become smaller, and be absorbed."
"Cancerine No. 1. . . . Tendency is to convert the sore from an unhealthy to a healthy condition and promote healing. Also it destroys and removes dead and unhealthy tissue."
In each case, the indictment alleged that the article was "wholly worthless," as the defendant well knew.
In quashing the indictment, the district court construed the statute. The substance of the decision is found in the following words of the opinion:
"Having regard to the intendment of the whole act, which is to protect the public health against adulterated, poisonous, and deleterious food, drugs, etc., the labeling or branding of the bottle or container, as to the quantity or composition of 'the ingredients or substances contained therein, which shall be false or misleading,' by no possible construction can be extended to an inquiry as to whether or not the prescription be efficacious or worthless to effect the remedy claimed for it."
And question on this writ of error is whether or not this construction is correct. United States v. Keitel, 211 U. S. 370.
What, then, is the true meaning of the statute?
Section 8 provides:
"SEC. 8. That the term 'misbranded,' as used herein, shall apply to all drugs, or articles of food, or articles which enter into the composition of food, the package or label of which shall bear any statement, design, or device regarding such article, or the ingredients or substances contained therein, which shall be false or misleading in any
particular, and to any food or drug product which is falsely branded as to the state, territory, or country in which it is manufactured or produced."
The words "such article" in this section, as is shown by the immediate context, refer to "drugs" as well as to "food."
"Drugs" are thus defined in § 6:
"SEC. 6. That the term 'drug,' as used in this act, shall include all medicines and preparations recognized in the United States Pharmacopoeia or National Formulary for internal or external use, and any substance or mixture of substances intended to be used for the cure, mitigation, or prevention of disease of either man or other animals."
Articles, then, intended to be used for curative purposes, such as those described in the indictment, are within the statute, though they are not recognized in the United States Pharmacopoeia or the National Formulary. And the offense of misbranding is committed if the package or label of such an article bears any statement regarding it "which shall be false or misleading in any particular."
But it is said that these words refer only to false statements which fix the identity of the article. According to the construction placed upon the statute by the court below in quashing the indictment, if one puts upon the market, in interstate commerce, tablets of inert matter or a liquid wholly worthless for any curative purpose, as he well knows, with the label "Cancer Cure" or "Remedy for Epilepsy," he is not guilty of an offense, for, in the sense attributed by that construction to the words of the statute, he has not made a statement regarding the article which is false or misleading in any particular.
I fail to find a sufficient warrant for this limitation, and, on the contrary, it seems to me to be opposed to the intent of Congress, and to deprive the Act of a very salutary effect.
It is strongly stated that the clause in § 8 -- "or the ingredients or substances contained therein" -- has reference to identity, and that this controls the interpretation of the entire provision. This, in my judgment, is to ascribe an altogether undue weight to the wording of the clause and to overlook the context. The clause, it will be observed, is disjunctive. If Congress had intended to restrict the offense to misstatements as to identity, it could easily have said so. But it did not say so. To a draftsman with such a purpose, the language used would not naturally occur. Indeed, as will presently be shown, Congress refused, with the question up, so to limit the statute.
Let us look at the context. In the very next sentence, the section provides (referring to drugs) that an article shall "also" be deemed to be misbranded if it be "an imitation of, or offered for sale under the name of, another article," or in case of substitution of contents, or of failure to disclose the quantity or proportion of certain specified ingredients, if present, such as alcohol, morphine, opium, cocaine, etc.
It is a matter of common knowledge that the "substances" or "mixtures of substances" which are embraced in the act, although not recognized by the United States Pharmacopoeia or National Formulary, are sold under trade names without any disclosure of constituents save to the extent necessary to meet the specific requirements of the statute. Are the provisions of the section to which we have referred, introduced by the word "also," and the one relating to the place of manufacture, the only provisions as to descriptive statements which are intended to apply to these medicinal preparations? Was it supposed that, with respect to this large class of compositions, nothing being said as to ingredients except as specifically required, there could be, within the meaning of the act, no false or misleading statement in
any particular? If false and misleading statements regarding such articles were put upon their labels, was it not the intent of Congress to reach them? And was it not for this very purpose that the general language of § 8 was used?
The legislative history of the section would seem to negative the contention that Congress intended to limit the provision to statements as to identity. The provision in question as to misbranding, as it stood in the original bill in the Senate (then § 9), was as follows:
"If the package containing it, or its label, shall bear any statement regarding the ingredients or the substances contained therein, which statement shall be false or misleading in any particular."
The question arose upon this language whether or not it should be taken as limited strictly to statements with respect to identity. It was insisted that the words had a broader range, and the effort was made to procure an amendment which should be so specific as to afford no basis for the conclusion that anything but false statements as to identity or constituents was intended. An amendment was then adopted in the Senate, making the provision read:
"any statement as to the constituent ingredients, or the substances contained therein, which statements shall be false or misleading in any particular."
With this amendment, the bill was passed by the Senate and went to the House. There, the provision was changed by striking out the word "constituent," and inserting the word "regarding," so that it should read:
"any statement regarding the ingredients or substances contained in such article, which statement shall be false or misleading in any particular."
Finally, it appears that, in conference, the bill was amended by inserting the word "design, or device," and also the words "such article, or," and thus the section became
a part of the law in its present form -- containing the words:
"any statement, design, or device regarding such article, or the ingredients or substances contained therein, which shall be false or misleading in any particular."
It is difficult to support that, the question distinctly raised, Congress would have rejected the provision of the Senate bill, and broadened the language in the manner stated, if it had been intended to confine the prohibition to false statements as to identity. Reading the act with the sole purpose of giving effect to the intent of Congress, I cannot escape the conclusion that it was designed to cover false and misleading statements of fact on the packages or labels of articles intended for curative purposes, although the statements relate to curative properties.
It is, of course, true that, when Congress used the words "false or misleading statement," it referred to a well defined category in the law, and must be taken to have intended statements of fact, and not mere expressions of opinion.
The argument is that the curative properties of articles purveyed as medicinal preparations are matters of opinion, and the contrariety of views among medical practitioners, and the conflict between the schools of medicine, are impressively described. But, granting the wide domain of opinion and allowing the broadest range to the conflict of medical views, there still remains a field in which statements as to curative properties are downright falsehoods and in no sense expressions of judgment. This field I believe this statute covers.
The construction which the district court has placed upon this statute is that it cannot be extended to any case where the substance labeled as a cure, with a description of curative properties, is "wholly worthless" and is known by the defendant to be such. That is the charge of the indictment.
The question, then, is whether, if an article is shipped in interstate commerce, bearing on its label a representation that it is a cure for a given disease, when, on a showing of the facts, there would be a unanimous agreement that it was absolutely worthless and an out-and-out cheat, the act of Congress can be said to apply to it. To my mind, the answer appears clear. One or two hypothetical illustrations have been given above. Others may readily be suggested. The records of actual prosecutions, to which I am about to refer, show the operation the statute has had, and I know of no reason why this should be denied to it in the future.
Our attention has been called to the construction which was immediately placed upon the enactment by the officers charged with its enforcement in the Department of Justice and the Department of Agriculture. It is true that the statute is a recent one, and, of course, the question is one for judicial decision. But it is not amiss to note that the natural meaning or the words used in the statute, reflected in the refusal of Congress to adopt a narrower provision, was the meaning promptly attributed to it in the proceedings that were taken to enforce the law. And this appears to have been acquiesced in by the defendants in many prosecutions in which the defendants pleaded guilty. We have been referred to the records of the Department of Agriculture, showing nearly thirty cases in which either goods had been seized and no defense made, or pleas of guilty had been entered. Among these are found such cases as the following:
"No. 29. Hancock's Liquid Sulphur, falsely represented, among other things, to be 'nature's greatest germicide. . . . The great cure for . . . diphtheria.' Investigation begun November 22, 1907. Plea of guilty."
"No. 180. Gowan's Pneumonia Cure, falsely represented, among other things, that it 'supplies an easily
absorbed food for the lungs that quickly effects a permanent cure.' Investigation begun November 22, 1907. Criminal information. Plea of guilty."
"No. 181. 'Eyelin,' falsely represented, among other things, that it 'repairs and rejuvenates the eye and sight.' Investigation begun February 13, 1908. Plea of guilty."
"No. 261. 'Sure Thing Tonic,' falsely represented, among other things, to be 'sure thing tonic. . . . Restores nerve energy. Renews vital force.' Investigation begun June 3, 1909. Pleaded guilty."
"No. 424. 'Tuckahoe Lithia Water,' falsely represented, among other things, to be 'a sure solvent for calculi, either of the kidneys or liver, especially indicated in all diseases due to uric diathesis, such as gout, rheumatism, gravel stone, incipient diabetes, Bright's Disease, inflamed bladder, eczema, stomach, nervous, and malarial disorders.' Investigation begun July 9, 1908. Plea of guilty."
"No. 427. 'Cancerine,' falsely represented, among other things, to be 'a remarkably curative extract, which, if faithfully adhered to, will entirely eradicate cancerous poison from the system. . . . A specific cure for cancer in all its forms.' Investigation begun about April 12, 1909. Criminal information. Plea of guilty."
I find nothing in the language of the statute which requires the conclusion that these persons who have confessed their guilt in making false and misleading statements on their labels should be privileged to conduct their interstate traffic in their so-called medicines, admittedly worthless, because Congress did not intend to reach them.
Nor does it seem to me that any serious question arises in this case as to the power of Congress. I take it to be conceded that misbranding may cover statements as to strength, quality, and purity. But so long as the statement is not as to matter of opinion, but consists of a false
representation of fact -- in labeling the article as a cure when it is nothing of the sort from any point of view, but wholly worthless -- there would appear to be no basis for a constitutional distinction. It is nonetheless descriptive, and falsely descriptive, of the article. Why should not worthless stuff, purveyed under false labels as cures, be made contraband of interstate commerce, as well as lottery tickets? Champion v. Ames, 188 U. S. 321.
I entirely agree that in any case brought under the act for misbranding -- by a false or misleading statement as to curative properties of an article -- it would be the duty of the court to direct an acquittal when it appeared that the statement concerned a matter of opinion. Conviction would stand only where it had been shown that, apart from any question of opinion, the so-called remedy was absolutely worthless, and hence the label demonstrably false; but, in such case, it seems to me to be fully authorized by the statute.
Accordingly, I reach the conclusion that the court below erred in the construction that it gave the statute, and hence in quashing the indictment, and that the judgment should be reversed.
I am authorized to say that MR. JUSTICE HARLAN and MR. JUSTICE DAY concur in this dissent.